These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 6135830
1. An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis. Warrell MJ, Warrell DA, Suntharasamai P, Viravan C, Sinhaseni A, Udomsakdi D, Phanfung R, Xueref C, Vincent-Falquet JC, Nicholson KG, Bunnag D, Harinasuta T. Lancet; 1983 Aug 06; 2(8345):301-4. PubMed ID: 6135830 [Abstract] [Full Text] [Related]
3. Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Warrell MJ, Nicholson KG, Warrell DA, Suntharasamai P, Chanthavanich P, Viravan C, Sinhaseni A, Chiewbambroongkiat MK, Pouradier-Duteil X, Xueref C. Lancet; 1985 May 11; 1(8437):1059-62. PubMed ID: 2860284 [Abstract] [Full Text] [Related]
4. Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses. Bernard KW, Roberts MA, Sumner J, Winkler WG, Mallonee J, Baer GM, Chaney R. JAMA; 1982 Feb 26; 247(8):1138-42. PubMed ID: 7057603 [Abstract] [Full Text] [Related]
5. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine. Gherardin AW, Scrimgeour DJ, Lau SC, Phillips MA, Kass RB. J Travel Med; 2001 Feb 26; 8(3):122-6. PubMed ID: 11468113 [Abstract] [Full Text] [Related]
6. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis. Wongsaroj P, Udomchaisakul P, Tepsumethanon S, Khawplod P, Tantawichien T. Vaccine; 2013 Mar 25; 31(13):1748-51. PubMed ID: 23370149 [Abstract] [Full Text] [Related]
8. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C. Vaccine; 2006 May 08; 24(19):4116-21. PubMed ID: 16545510 [Abstract] [Full Text] [Related]